clinical trial

[키워드] accelerate acute respiratory syndrome Admission antiviral drug antiviral intervention Arbidol Care caused China clinical trial comparable control group corona virus disease 2019 coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient death defined Effectiveness Efficacy Hospital stay ICU IMPROVE in both groups Influenza interquartile range IQR laboratory characteristics median time negative test negativity non-ICU patients nucleic acid objective onset of symptom outcome Patient Pharyngeal swab polymerase chain Prognosis Randomized Result Retrospective study RT-PCR Russia SARS-CoV-2 SARS-CoV-2 clearance severe adverse reaction specimens tested treat Treatment turn two groups umifenovir virus was performed
[DOI] 10.1016/j.cmi.2020.04.026 PMC 바로가기 [Article Type] Article